Search Results - "L. P. Mendeleeva"

Difficulties evaluating hematological response in patients with multiple myeloma and dialysis - dependent renal impairment by Rekhtina, I G, Mendeleeva, L P, Soboleva, N P

“…Aim: to determine serum free light chains (FLC) level by patients with multiple myeloma (MM) and dialysis - dependent renal impairment in which the amount…”
Get full text

Morphological and immunohistochemical predictors of renal response to therapy patients with myeloma cast nephropathy and dialysis-dependent acute kidney injury by Rekhtina, I G, Kazarina, E V, Stolyarevich, E S, Kovrigina, A M, Dvirnyk, V N, Kulikov, S M, Mendeleeva, L P

“…Reveal morphological and immunohistochemical predictors of reversibility of dialysis-dependent acute kidney injury (AKI) in patients with myeloma cast…”
Get full text

Bone disease as the first manifestation of systemic AL-amyloidosis by Mendeleeva, L P, Rekhtina, I G, Kovrigina, A M, Kostina, I E, Khyshova, V A, Arytyunyan, N K, Mamonov, W E, Savthenko, V G

“…Our case demonstrates severe bone disease in primary AL-amyloidosis without concomitant multiple myeloma. A 30-year-old man had spontaneous vertebral fracture…”
Get full text

Autologous haematopoietic stem cell transplantation in patients with multiple myeloma complicated by dialysis-dependent renal failure by Firsova, M V, Mendeleeva, L P, Solovev, M V, Rekhtina, I G, Pokrovskaya, O S, Urnova, E S, Soboleva, N P, Dvirnyk, V N, Klyasova, G A, Kuzmina, L A, Savchenko, V G

“…To assess the safety and efficacy of autologous haematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients with dialysis-dependent…”
Get full text

Light-chain deposition disease is a hematologic problem by Rekhtina, I G, Mendeleeva, L P, Biryukova, L S

“…To analyze clinical and laboratory data and treatment results in patients with light-chain deposition disease (LCDD). Nine patients with LCDD and kidney injury…”
Get full text

Monoclonal gammopathy of renal significance: consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment by Smirnov, A V, Afanasyev, B V, Poddubnaya, I V, Dobronravov, V A, Khrabrova, M S, Zakharova, E V, Nikitin, E A, Lysenko Kozlovskaya, L V, Bobkova, I N, Rameev, V V, Batyushin, M M, Moiseev, I S, Darskaya, E I, Pirogova, O V, Mendeleeva, L P, Biryukova, L S

“…Monoclonal gammopathy of renal significance (MGRS) is a new nosology in modern nephrology and oncohematology. MGRS is defined as kidney injury due to…”
Get full text

Dialysis-dependent renal failure in patients with multiple myeloma: Reversibility factors by Rekhtina, I G, Mendeleeva, L P, Biryukova, L S

“…To establish the reversibility factors of dialysis-dependent renal failure (RF) in patients with multiple myeloma (MM) treated according to…”
Get full text

Uromodulin gene polymorphisms in patients with cast nephropathy in multiple myeloma by Rekhtina, I G, Mendeleeva, L P, Biderman, B V, Solovyev, M V, Sudarikov, A B

“…To investigate the nature of mutations in exons 4 and 5 of the uromodulin (UM) gene, including in the area encoding the domain of 8 cysteines (D8C), in…”
Get full text

Secondary monoclonal gammopathy after bone marrow autotransplantation as a cause of worse renal function in light chain immunoglobulin deposition disease by Rekhtina, I G, Mendeleeva, L P, Stolyarevich, E S, Galtseva, I V, Povilaitite, P E, Biryukova, L S

“…The paper describes a clinical case of a female woman with nephropathy due to light chain deposition disease caused by secretion of κ Bence-Jones protein…”
Get full text

Absolute numbers of peripheral blood CD34+ hematopoietic stem cells prior to a leukapheresis procedure as a parameter predicting the efficiency of stem cell collection by Galtseva, I V, Davydova, Yu O, Gaponova, T V, Kapranov, N M, Kuzmina, L A, Troitskaya, V V, Gribanova, E O, Kravchenko, S K, Mangasarova, Ya K, Zvonkov, E E, Parovichnikova, E N, Mendeleeva, L P, Savchenko, V G

“…To identify a parameter predicting a collection of at least 2·106 CD34+ hematopoietic stem cells (HSC)/kg body weight per leukapheresis (LA) procedure. The…”
Get full text

Specifics of the telemedicine in patients with paraproteinemic hemoblastoses by Soloveva, M. V., Solovev, M. V., Mendeleeva, L. P.

“…Background. Medical care through telemedicine technologies for plasma cell tumors has been provided at the National Medical Research Center for Hematology…”
Get full text

Characteristics of telomere length in patients with hematological diseases (literature review) by Kondratieva, Yu. A., Mendeleeva, L. P.

“…Telomeres are protein structures that regulate the process of cellular aging and play the role of a protective “cap” on the end sections of chromosomes. The…”
Get full text

Prevention and management of bortezomib-induced peripheral neuropathy in patients with multiple myeloma by Semochkin, S. V., Solovyev, M. V., Mendeleeva, L. P.

“…Proteasome inhibitors and immunomodulators (IMiDs), primarily bortezomib and lenalidomide, are essential components of treatment for both newly diagnosed and…”
Get full text

Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells by Fink, E E, Mannava, S, Bagati, A, Bianchi-Smiraglia, A, Nair, J R, Moparthy, K, Lipchick, B C, Drokov, M, Utley, A, Ross, J, Mendeleeva, L P, Savchenko, V G, Lee, K P, Nikiforov, M A

“…It is generally accepted that intracellular oxidative stress induced by proteasome inhibitors is a byproduct of endoplasmic reticulum (ER) stress. Here we…”
Get full text

Informative value of whole-body magnetic resonance imaging with diffusion-weighted images for the detection of bone marrow infiltration in patients with multiple myeloma (literature review) by Lutsik, N. S., Mendeleeva, L. P., Yatsik, G. A.

“…Magnetic resonance imaging (MRI) is increasingly being used to diagnose bone marrow lesions in patients with multiple myeloma (MM). Since 2014, the results of…”
Get full text

Prevention of thrombotic complications in patients with AL amyloidosis by Khyshova, V. A., Rekhtina, I. G., Zozulya, N. I., Gribkova, I. V., Mendeleeva, L. P.

“…Background. The problem of hemostasis system pathology in patients with AL amyloidosis (AL-A) is of great practical importance. Currently, there are no…”
Get full text

Pain syndrome in multiple myeloma (results of a single-center study) by Soloveva, M. V., Solovev, M. V., Irugova, E. Z., Startsev, A. A., Arutyunyan, N. K., Krayzman, A. A., Abakumova, A. V., Mendeleeva, L. P.

“…Background. One of the most common symptoms of multiple myeloma (MM) is pain. Bone pain is observed in 60– 80 % of patients at the disease onset. Neuropathic…”
Get full text

Whole-body low-dose computed tomography in primary patients with multiple myeloma by Danilina, A. M., Mendeleeva, L. P., Kostina, I. E., Gribanova, E. O., Ryzhko, V. V., Bal'zhanova, Ya. B.

“…Imaging of bone lesions has an important role in diagnosis of multiple myeloma (MM) and evaluating the response to treatment. Computed tomography scan (CT)…”
Get full text

Clinical features of multiple myeloma with bone plasmacytomas by Mamaeva, E. A., Soloveva, M. V., Solovev, M. V., Kovrigina, A. M., Danilina, T. P., Mendeleeva, L. P.

“…Background. Multiple myeloma (MM) is a plasma cell tumour, which could be followed by formation of bone plasmacytomas. Bone plasmacytoma is plasma cells…”
Get full text

Difficulties in diagnosis of primary AL-amyloidosis by Khyshova, V. A., Rekhtina, I. G., Firsova, M. V., Mendeleeva, L. P.

“…Objective of the study : analysis of AL-amyloidosis (AL-A) diagnostics in real clinical practice and to determine the main approaches for the earlier detection…”
Get full text